|
Octapharma is committed to supporting clinical and pre-clinical research projects that promote excellence in patient care and provide valuable information to the medical and patient community that may translate to better management of disease and improvement in patient safety and population health.
To qualify, the request for support must relate to clinical or pre-clinical research focusing on human protein therapies in one or more of the following therapeutic areas:
• Immunotherapy
• Coagulation Disorders
• Intensive Care and Emergency Medicine
• Grants for general operating expenses, capital building costs
• Grants for animal health care or research
• Grants to political, religious, fraternal, discriminatory or for-profit organizations such as pharmaceutical companies, homecare companies, health maintenance organizations, specialty pharmacies and group purchasing organizations
• Free-of-charge product will not be supplied under the Grants program
• Charitable donations
• Continuing education credit fees/tuition, travel or lodging for a healthcare professional to attend an education and/or scientific conference
• Travel fellowships
• Programs that do not primarily benefit patient care or advance medical science
• Requests for grants or donations that are not of a scientific interest to Octapharma
• Grants requests for organizations or activities outside of the US. For such requests, please contact your local Octapharma office. Contact details can be found by following this link.
Unfortunately, previous support of a program does not guarantee future support. The grants selection process evaluates each grant application and will determine acceptance and level of support for each individual grant request. The requests are not approved until the applicant receives a written confirmation from the Octapharma Grants Committee.
The Octapharma Grants Program can be withdrawn at the discretion of Octapharma USA at any time. |
